Navid Zaer, MD
Diagnostic Radiology · Houston, TXNPI 1811150386
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,084, 5.2 times the $209 reported in 2019. Among diagnostic radiology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $29.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$481
- Stryker$373
- Merck$361
- Bayer$360
- Inari Medical, Inc.$303
- Seagen Inc.$277
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,089100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $481 |
| Stryker | 11 | $373 |
| Merck | 15 | $361 |
| Bayer | 12 | $360 |
| Inari Medical, Inc. | 9 | $303 |
| Seagen Inc. | 10 | $277 |
| Exelixis Inc. | 6 | $239 |
| Eisai Inc. | 8 | $218 |
| E.r. Squibb & Sons, L.L.C. | 6 | $146 |
| Incyte Corporation | 6 | $136 |
| Medtronic | 2 | $107 |
| Gilead | 3 | $87 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $80 |
| Johnson & Johnson | 2 | $68 |
| Mirati Therapeutics, Inc. | 2 | $64 |
| Geron Corporation | 2 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Boston Scientific | 3 | $60 |
| Sobi, Inc | 2 | $58 |
| Penumbra, Inc. | 2 | $58 |
| Beigene USA, Inc. | 2 | $57 |
| AbbVie | 2 | $55 |
| Amgen | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Blue Earth Diagnostics | 1 | $33 |
| Bard Peripheral Vascular, Inc. | 1 | $28 |
| Sirtex Medical Inc | 1 | $27 |
| Z-medica, LLC | 1 | $26 |
| Servier Pharmaceuticals LLC | 1 | $25 |
| Terumo Medical Corporation | 1 | $24 |
| Myovant Sciences Inc. | 1 | $24 |
| Bristol Myers Squibb | 1 | $23 |
| Cordis US CORP. | 1 | $22 |
| Lilly USA, LLC | 1 | $17 |
| Trisalus Life Sciences, Inc. | 1 | $17 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Cardinal Health 200 LLC | 1 | $15 |
How this compares
$4,089 in reported general payments places this provider in the 90th percentile of 2,506 diagnostic radiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in Houston
- Harlan HarveyHouston$583K
- Sasidhar YallampalliHouston$263K
- Debra ButlerHouston$262K
- Melissa PriceHouston$233K
- Vivek BansalHouston$173K
- Stephen RoseHouston$163K
- Sankaman PraisoodyHouston$147K
- John LeeHouston$121K
- Nakul GuptaHouston$80K
- Tanya MoseleyHouston$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.